Routh Janell A, Sreenivasan Nandini, Adhikari Bishwa B, Andrecy Lesly L, Bernateau Margarette, Abimbola Taiwo, Njau Joseph, Jackson Ernsley, Juin Stanley, Francois Jeannot, Tohme Rania A, Meltzer Martin I, Katz Mark A, Mintz Eric D
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia.
Division of Preparedness and Emerging Infections, National Center for Emerging Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Am J Trop Med Hyg. 2017 Oct;97(4_Suppl):37-42. doi: 10.4269/ajtmh.16-1023.
The devastating 2010 cholera epidemic in Haiti prompted the government to introduce oral cholera vaccine (OCV) in two high-risk areas of Haiti. We evaluated the direct costs associated with the government's first vaccine campaign implemented in August-September 2013. We analyzed data for major cost categories and assessed the efficiency of available campaign resources to vaccinate the target population. For a target population of 107,906 persons, campaign costs totaled $624,000 and 215,295 OCV doses were dispensed. The total vaccine and operational cost was $2.90 per dose; vaccine alone cost $1.85 per dose, vaccine delivery and administration $0.70 per dose, and vaccine storage and transport $0.35 per dose. Resources were greater than needed-our analyses suggested that approximately 2.5-6 times as many persons could have been vaccinated during this campaign without increasing the resources allocated for vaccine delivery and administration. These results can inform future OCV campaigns in Haiti.
2010年海地爆发的毁灭性霍乱疫情促使该国政府在海地的两个高风险地区引入了口服霍乱疫苗(OCV)。我们评估了与2013年8月至9月实施的政府首次疫苗接种运动相关的直接成本。我们分析了主要成本类别的数据,并评估了可用运动资源为目标人群接种疫苗的效率。对于107,906人的目标人群,运动成本总计624,000美元,分发了215,295剂口服霍乱疫苗。疫苗和运营总成本为每剂2.90美元;仅疫苗成本为每剂1.85美元,疫苗交付和接种成本为每剂0.70美元,疫苗储存和运输成本为每剂0.35美元。资源超出了需求——我们的分析表明,在不增加分配用于疫苗交付和接种的资源的情况下,此次运动期间可以接种的人数大约是实际接种人数的2.5至6倍。这些结果可为海地未来的口服霍乱疫苗接种运动提供参考。